Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey
The Physician Payments Sunshine Act, part of the Affordable Care Act, requires pharmaceutical and medical device firms to report payments they make to physicians and, through its Open Payments program, makes this information publicly available.
To establish estimates of the exposure of the American patient population to physicians who accept industry payments, to compare these population-based estimates to physician-based estimates of industry contact, and to investigate Americans’ awareness of industry payments.
Cross-sectional survey conducted in late September and early October 2014, with data linkage of respondents’ physicians to Open Payments data.
A total of 3542 adults drawn from a large, nationally representative household panel.
Respondents’ contact with physicians reported in Open Payments to have received industry payments; respondents’ awareness that physicians receive payments from industry and that payment information is publicly available; respondents’ knowledge of whether their own physician received industry payments.
Among the 1987 respondents who could be matched to a specific physician, 65% saw a physician who had received an industry payment during the previous 12 months. This population-based estimate of exposure to industry contact is much higher than physician-based estimates from the same period, which indicate that 41% of physicians received an industry payment. Across the six most frequently visited specialties, patient contact with physicians who had received an industry payment ranged from 60 to 85%; the percentage of physicians with industry contact in these specialties was much lower (35–56%). Only 12% of survey respondents knew that payment information was publicly available, and only 5% knew whether their own doctor had received payments.
Patients’ contact with physicians who receive industry payments is more prevalent than physician-based measures of industry contact would suggest. Very few Americans know whether their own doctor has received industry payments or are aware that payment information is publicly available.
KEY WORDSfinancial conflicts of interest physician-industry relationships industry payments physician payments sunshine act open payments
We are grateful to the Greenwall Foundation for its financial support of this project. The sponsor played no role in the design or conduct of the study or the interpretation of results. Drs. Campbell, Carpenter, and Lehmann were supported in part by the Edmond J. Safra Foundation through the Harvard University Edmond J. Safra Center for Ethics. We thank Charles V. Gray, Alec McQuilkin, and Melanie Mason for research assistance, Wayne Appleton for technical support, Mary Baitinger for administrative assistance, and Wendy Mansfield and Sergei Rodkin at GfK for coordinating the administration of the survey.
Compliance with Ethical Standards
The content is solely the responsibility of the authors and does not represent the official views of the Veterans Health Administration, the National Center for Ethics in Health Care, or the U.S. government.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
- 1.Section 6002 of the Patient Protection and Affordable Care Act. Public Law 111–148. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed 26 Jan 2017.
- 2.Centers for Medicare and Medicaid Services. 42 CFR Parts 402 and 403. Medicare, Medicaid, Children’s Health Insurance Programs; transparency reports and reporting of physician ownership or investment interests. Federal Register 78. 2013. https://www.cms.gov/OpenPayments/Downloads/Affordable-Care-Act-Section-6002-Final-Rule.pdf. Accessed 26 Jan 2017.
- 3.Official website for Open Payments. https://www.cms.gov/OpenPayments/index.html. Accessed 26 Jan 2017.
- 4.US Senate Special Committee on Aging. Grassley, Kohl say public should know when pharmaceutical makers give money to doctors. Press release. September 7, 2007. http://www.aging.senate.gov/press-releases/grassley-kohl-say-public-should-know-when-pharmaceutical-makers-give-money-to-doctors. Accessed 26 Jan 2017.
- 9.Lo B, Field MJ, eds. Conflict of interest in medical research, education, and practice. Washington, DC: National Academies Press; 2009.Google Scholar
- 15.Pham-Kanter G. Act II of the Sunshine Act. PLoS Med. 2014; e1001754.Google Scholar
- 23.Pew Research Center. Assessing the representativeness of public opinion surveys. 2012. http://www.people-press.org/2012/5/15/assessing-the-representativeness-of-public-opinion-surveys. Accessed 26 Jan 2017.
- 24.Manfreda KL, Bosnjak M, Berzelak J, Haas I, Vehovar V. Web surveys versus other survey modes: a meta-analysis comparing response rates. Int J Mark Res. 2008;50:79–104.Google Scholar
- 25.National Research Council. Nonresponse in social science surveys: a research agenda. Tourangeau R, Plewes TJ, eds. Panel on a research agenda for the future of social science data collection, Committee on National Statistics, Division of Behavioral and Social Sciences and Education, National Research Council. Washington, DC: National Academies Press; 2013.Google Scholar